Biomarkers of endothelial dysfunction in preeclampsia and neonatal morbidity: A case-control study

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 175, Issue 1, 2014, Pages 119-123

  Masoura, Sophia ^a   Kalogiannidis, Ioannis ^a   Makedou, Kali ^a   Theodoridis, Theodoros ^a   Koiou, Katerina ^a   Gerou, Spiros ^b   Athanasiadis, Apostolos ^a   Agorastos, Theodoros ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b Laboratories Analysis   (Greece)

Author keywords

PlGF; Preeclampsia; sFlt 1; VEGF

Indexed keywords

BIOLOGICAL MARKER; PLACENTAL GROWTH FACTOR; SFLT 1 PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN; FLT1 PROTEIN, HUMAN; PLACENTA PROTEIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1; VEGFA PROTEIN, HUMAN;

ADULT; ADVERSE OUTCOME; ANGIOGENESIS; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DELIVERY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; INTRAUTERINE GROWTH RESTRICTION; LOW BIRTH WEIGHT; MATERNAL AGE; NEONATAL OUTCOME; NEWBORN INTENSIVE CARE; NEWBORN MORBIDITY; PREECLAMPSIA; PREMATURITY; PRENATAL GROWTH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; TERM BIRTH; VERY LOW BIRTH WEIGHT; BLOOD; BLOOD PRESSURE; NEWBORN; NEWBORN DISEASE; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY OUTCOME; STATISTICAL MODEL; VASCULAR ENDOTHELIUM; YOUNG ADULT;

ADULT; BIOLOGICAL MARKERS; BLOOD PRESSURE; CASE-CONTROL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; LOGISTIC MODELS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; YOUNG ADULT;

EID: 84898059439     PISSN: 03012115     EISSN: 18727654     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2014.01.012     Document Type: Article

References (35)

1. J. Folkman Angiogenesis: an organizing principle for drug discovery Nature 6 2007 273 286
2. P. Carmeliet, Y. Ng, and D. Nuyens et al. Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF 164 and VEGF 188 Nat Med 5 1995 495 502
3. J. Moodley Maternal deaths due to hypertensive disorders in pregnancy. Saving Mothers Report 2002-2004 Cardiovasc J Afr 18 2007 358 361
4. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy Am J Obstet Gynecol 183 2000 1 22
5. P. Merviel, L. Carbillon, J.C. Challier, M. Rabreau, M. Beaufils, and S. Uzan Pathophysiology of preeclampsia: links with implantation disorders Eur J Obstet Gynecol Reprod Biol 115 2004 134 147
6. I.A. Brosens, W.B. Robertson, and H.G. Dixon The role of the spiral arteries in the pathogenesis of preeclampsia Obstet Gynecol Annu 1 1972 177 191
7. S. Baumwell, and S.A. Karumanchi Preeclampsia: clinical manifestations and molecular mechanisms Nephron Clin Pract 106 2007 72 81
8. A.K. Olsson, A. Dimberg, J. Kreuger, and L.C. Welsh VEGF receptor signaling in control of vascular function Nat Rev Mol Cell Biol 7 2006 359 371
9. N. Ferrara, H.P. Gerber, and J. LeCouter The biology of VEGF and its receptors Nat Med 9 2003 666 669
10. P.J. Keck, S.D. Hauser, and G. Krivi et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF Science 246 1989 1309 1312
11. D. Ribatti The discovery of the placental growth factor and its role in angiogenesis: a historical review Angiogenesis 11 2008 215 221
12. R.L. Kendal, and K.A. Thomas Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor Proc Acad Sci USA 90 1993 10705 10709
13. S. Cebe-Suarez, A. Zehnder-Fjallman, and K. Ballmer-Hofer The role of vascular endothelial growth factor in angiogenesis: complex partnerships Cell Mol Life Sci 63 2006 601 615
14. M. Shibuya, and L. Claesson-Welsh Signal transduction by VEGF in regulation of angiogenesis and lymphangiogenesis Exp Cell Res 312 2005 549 560
15. A. Leanos-Miranda, I. Campos-Galicia, K.L. Ramirez-Valenzuela, Z.L. Chinolla-Arellano, and I. Isordia-Salas Circulating angiogenic factors and urinary prolactin as predictors of adverse outcomes in women with preeclampsia Hypertension 61 2013 1118 1125
16. M.L. Tjoa, R.J. Levine, and S.A. Karumanchi Angiogenic factors and preeclampsia Front Biosci 12 2007 2395 2402
17. T.A. Moore Simas, S.L. Crawford, M.J. Solitro, S.C. Frost, B.A. Meyer, and S.E. Maynard Angiogenic factors for the prediction of preeclampsia in high risk women Am J Obstet Gynecol 197 2007 244.el-8
18. A.K. Wilkström, A. Larsson, U.J. Eriksson, P. Nash, S. Nordén-Lindeberg, and M. Olovsson Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia Obstet Gynecol 109 2007 1368 1374
19. A. De Vivo, G. Baviera, D. Giordano, G. Todarello, F. Corrado, and R. D'anna Endoglin, PLGF and sFLt-1 as markers for predicting pre-eclampsia Acta Obstet Gynecol Scand 87 2008 837 842
20. F. Lyall, I.A. Greer, F. Boswell, and R. Fleming Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and preeclampsia Br J Obstet Gynecol 104 1997 223 228
21. B. Varughese, N. Bhatka, R. Kumar, S.N. Dwivedi, and R. Dhingra Circulating angiogenic factors in pregnancies complicated by preeclampsia Natl Med J India 23 2010 77 81
22. S.E. Maynard, J.Y. Min, and J. Merchan et al. Excess placental soluble Fms-like tyrosine kinase-1 (sFlt-1) may contribute to endothelial dysfunction, hypertension and proteinuria in preeclampsia J Clin Invest 111 2003 649 658
23. S.E. Maynard, S. Venkatesha, R. Thadhani, and S.A. Karumanchi Soluble fms-like tyrosine kinase-1 and endothelial dysfunction in the pathogenesis of preeclampsia Pediatr Res 57 2005 1R 7R
24. T. Alon, I. Hemo, A. Itin, J. Pe'er, J. Stone, and E. Keshet Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity Nat Med 1 1995 1024 1028
25. H.P. Gerber, V. Dixit, and N. Ferrara Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells J Biol Chem 273 1998 13313 13316
26. L.E. Benjamin, D. Golijanin, A. Itin, D. Pode, and E. Keshet Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal J Clin Invest 103 1999 159 165
27. R. Yang, G.R. Thomas, and S. Bunting et al. Effects of vascular endothelial growth factor on hemodynamics and cardiac performance J Cardiovasc Pharmacol 27 1996 838 844
28. M. Auterio, J. Waltenberger, and D. Communi et al. Role of PLGF in the intra- and intermolecular cross talk between the VEGF receptors flt1 and flk1 Nat Med 9 2003 936 943
29. R.J. Levine, Se. Maynard, and C. Qian et al. Circulating angiogenic factors and the risk of preeclampsia N Engl J Med 12 2004 672 683
30. B.M. Sibai, and W.C. Mabie Hemodynamics of preeclampsia Clin Perinatol 18 1991 727 747
31. P.M. Bosio, P.J. McKenna, R. Conroy, and C. O'Herlihy Maternal hemodynamics in hypertensive disorders of pregnancy Obstet Gynecol 94 1999 978 984
32. J.U. Hibbard, Sg. Shroff, and R.M. Lang Cardiovascular changes in preeclampsia Semin Nephrol 24 2004 580 587
33. S. Masoura, I. Kalogiannidis, and C. Margioula-Siarkou et al. Neonatal outcome of late preterm deliveries with preeclampsia Minerva Gynecol 64 2012 109 115
34. J. Villar, G. Carroli, and D. Wojdyla et al. Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions Am J Obstet Gynecol 194 2006 921 931
35. S.K. Srinivas, A.G. Edlow, P.M. Neff, M.D. Sammel, C.M. Andrela, and M.A. Elovitz Rethinking IUGR in preeclampsia: dependent or independent of maternal hypertension J Perinatol 29 2009 680 684